Results 221 to 230 of about 6,262,057 (305)

The Effect of a Parent Advocacy Intervention on Service Access for Autistic Youth: The Moderating Role of Baseline Advocacy Ability

Autism Research, EarlyView.
ABSTRACT Autistic youth face significant challenges accessing adult disability services as they transition out of school‐based services. Advocating for Supports to Improve Service Transitions (ASSIST), a group‐based program, was developed to address this issue by teaching parents about the service system and how to advocate for services for their youth.
Carly Moser, Leann Smith DaWalt, Meghan M. Burke, Julie Lounds Taylor   +3 more
wiley   +1 more source

Medical insurance coverage and its associated factors among children in urban and rural Chongqing, China. [PDF]

Int Health
Hu C, Chen J, Chen L, Yao X, Luo S, Jiang X, Chen L, Wang F, Li J, Liu J, Zheng S, Liang X.   +11 more
europepmc   +1 more source

Emotion Regulation Difficulties in Autism‐PTSD Co‐Occurrence

Autism Research, EarlyView.
ABSTRACT Autistic individuals face an increased risk of experiencing traumatic events and of being significantly affected by them, whether these events are life‐threatening or social in nature. Emotion regulation (ER) difficulties are central to both conditions, yet their role in this neuropsychiatric co‐occurrence remains under‐researched.
Eldar Fayena, Shir Shaked‐Ashkenazi, Michal Shoval, Mordi Benhamou, Nathaniel Laor, Danny Horesh, Ofer Golan   +6 more
wiley   +1 more source

Frequency, diagnosis, and management of polymyalgia rheumatica in Germany-database analysis of medical insurance data. [PDF]

Rheumatology (Oxford)
Schmidt WA, Alibone M, Ludwig P, Obermüller D, Karl F, Terner S, Venhoff N.   +6 more
europepmc   +1 more source

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

Medical insurance-related professionals' identification of the benefits of the medical insurance system in Northeast China: a cross-sectional study. [PDF]

BMC Health Serv Res
Zhou Z, Liu H, Shan L, Li Y, Zhang X, Wang J, Kang Z, Jiao M, Hao Y, Chen Y, Wu Q.   +10 more
europepmc   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Governance of the risk of operating deficits in basic medical insurance funds in China: based on the data from City H for the period 2021-2025. [PDF]

BMC Health Serv Res
Sun J, Zhang X, Hu S, Xu L, Chen Y, Sun Y, Zheng H, Zhang L.   +7 more
europepmc   +1 more source

Redistributive effects of China's urban-rural resident basic medical insurance: a theoretical model and empirical analysis. [PDF]

Front Public Health
Ji W, Chu F, Qin Y.
europepmc   +1 more source

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source